wins US FDA approval for Imcivree (Setmelanotide) as the first treatment for acquired hypothalamic obesity, delivering 18.4% PBO-adjusted BMI reduction in P-III trial Subscribe to our weekly newsletter and never miss a beat: #rhythmpharmaceuticals #usfda #approval #imcivree #setmelanotide #acquiredhypothalamicobesity #piii #transcend #regulatory To view or add a comment, sign in Indias semaglutide moment is closer than it looks
10.1097/INF.0000000000002042 Pediatr Infect Dis J
If glutathione (GSH) levels are low, these toxins are not efficiently removed from the body and can cause damage to cellular DNA, cell membranes, and mitochondria, which can result in an array of symptoms and disease, contribute to existing medical conditions (such as infertility), and cause problems with pregnancy and the future health of the offspring
Judy J
Diagnosis and risk stratification of NAFLD should be led by your GP, typically using blood tests and scoring systems such as FIB-4 or the Enhanced Liver Fibrosis (ELF) test, in line with NICE guidance